Summary
The pharmacokinetics of cefonicid was studied in 17 children requiring antibiotic treatment for respiratory or urinary tract infections. After informed consent had been obtained from the parents, a single dose of cefonicid 50 mg/kg/body weight was given by intramuscular injection.
The mean peak serum concentration of 212.63 µg/ml was reached at 1.00 h, as absorption occurred at a very fast rate with a mean constant of 3.24 h−1. Mean values for half-life, apparent volume of distribution (Vz), total body clearance (CL), and renal clearance (CLR) were 3.24 h, 0.21 l·kg−1, 16.67 ml·min−1 and 13.60 ml·min−1 respectively. There was an inverse relationship between age and Vz, whereas CL and CLR were positively correlated with age. Cefonicid concentrations in urine were many times higher than the MICs of susceptible strains of bacteria.
The study demonstrated that i.m. cefonicid 50 mg·kg−1 gave serum concentrations well within the therapeutic range for susceptible bacteria, and that its pharmacokinetic properties allow single daily doses to be used to treat infections in children.
Similar content being viewed by others
References
Barriere SL, Hateway GJ, Gambertoglio JG, Lin ET, Conte JE Jr (1982) Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 21: 935–938
Blair AD, Maxwell BM, Forland SC, Jacob L, Cutler RE (1984) Cefonicid kinetics in subjects with normal and impaired renal function. Clin Pharmacol Ther 35: 798–803
Boreus LO (1982) Principles of pediatric pharmacology. Churchill Livingstone, Edinburgh, p 46
Brendel E, Zschunke M, Meineke I (1985) High-performance liquid chromatographic determination of cefonicid in human plasma and urine. J Chromatogr 339–359
Chadwick EG, Yogev R, Shulman ST, Weinfeld RE, Patel BS, Patel IH (1983) Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections. J Pediatr 102: 134–137
Conte IE Jr (1984) Clinical and economic impact of cefonicid: Overview and summary of the symposium. Rev Infect Dis 6 [Suppl 4]: S 777-S 782
Cruciani M, Savio S, Monzillo V, Concia E (1987) Farmacocinetica del cefonicid dopo somministrazione intramuscolare: concentrazioni ematiche, urinarie e nel tessuto polmonare. Farmac Therap 4 [Suppl 4]: 15–19
Dudley MN, Quintiliani R, Nightingale CH (1984) Review of cefonicid, a long-acting cephalosporin. Clin Pharm 3: 23–32
Gibaldi M, Perrier O (1982) Pharmacokinetics. Dekker New York
Kaye D (1984) An overview evaluation of cefonicid in infections of the urinary tract, lower respiratory tract, and skin and soft tissue. Rev Infect Dis 6 [Suppl 4]: S 835-S 838
Pitkin D, Dubb J, Actor P, Alexander F, Ehrlichs S, Familiar R, Stote R (1981) Kinetics and renal handling of cefonicid. Clin Pharmacol Ther 30: 587–593
Pontzer RE, Kaye D (1984) Cefonicid: a long-acting, second generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy 4: 325–331
Saltiel E, Brogden RN (1986) Cefonicid: A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 32: 222–259
Wagner JG (1976) Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm 4: 443
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Furlanut, M., D'Elia, R., Riva, E. et al. Pharmacokinetics of cefonicid in children. Eur J Clin Pharmacol 36, 79–82 (1989). https://doi.org/10.1007/BF00561029
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561029